Our understanding of the pathways that regulate lymphocyte metabolism, as well as the effects of metabolism and its products on the immune response, is still limited. We report that a metabolic program controlled by the transcription factors hypoxia inducible factor-1a (HIF1-a) and aryl hydrocarbon receptor (AHR) supports the differentiation of type 1 regulatory T cell (Tr1) cells. HIF1-a controls the early metabolic reprograming of Tr1 cells. At later time points, AHR promotes HIF1-a degradation and takes control of Tr1 cell metabolism. Extracellular ATP (eATP) and hypoxia, linked to inflammation, trigger AHR inactivation by HIF1-a and inhibit Tr1 cell differentiation. Conversely, CD39 promotes Tr1 cell differentiation by depleting eATP. CD39 also contributes to Tr1 suppressive activity by generating adenosine in cooperation with CD73 expressed by responder T cells and antigen-presenting cells. These results suggest that HIF1-a and AHR integrate immunological, metabolic and environmental signals to regulate the immune response. 
T cell activation triggers metabolic changes required to support the adaptive immune response [1] [2] [3] [4] [5] . Indeed, the differentiation of cytotoxic and interleukin (IL)-17-producing effector T cells (T helper 17 cells; T H 17 cells) requires a metabolic shift toward aerobic glycolysis that is controlled by the transcription factor HIF1-α (refs. [6] [7] [8] . Conversely, forkhead box p3-positive (Foxp3 + ) T reg cells and memory T cells are supported by oxidative phosphorylation 6, 9 . In addition, besides supplying energy and biosynthetic precursors, the metabolism also provides molecules that modulate the immune response through feedback-regulatory pathways 3, 10, 11 .
Tr1 cells are Foxp3 − regulatory CD4 + T cells that produce IL-10 and have non-redundant roles in the control of inflammation [12] [13] [14] . IL-27 is a growth and differentiation factor for Tr1 cells [15] [16] [17] . In addition, IL-21 produced by Tr1 cells acts in an autocrine manner to boost and stabilize their differentiation 18, 19 . The transcription factor AHR regulates IL-10 and IL-21 production in Tr1 cells 20, 21 , but our understanding of the mechanisms that control the differentiation of Tr1 cells and their metabolism is limited. Here we report that aerobic glycolysis supports Tr1 cell differentiation through a metabolic program controlled by HIF1-α and AHR. Moreover, we found that oxygen and extracellular ATP (eATP) regulate the differentiation of Tr1 cells through HIF1-α dependent mechanisms. Thus, our findings identify metabolic pathways that regulate the differentiation of Tr1 cells and provide potential targets for their therapeutic modulation in immune-mediated disorders.
RESULTS

AHR and STAT3 control CD39 expression in Tr1 cells
We detected the expression of Entpd1, which encodes the plasma membrane ectonucleotidase CD39, in Tr1 cells differentiated with IL-27 (Fig. 1a,b and Supplementary Fig. 1a-c) . CD39 catalyzes the degradation of eATP into adenosine monophosphate (AMP) 22 . In Foxp3 + induced regulatory T cells (iT reg cells), CD39 is co-expressed with the ecto-5′-nucleotidase CD73 (encoded by Nt5e) that degrades AMP to adenosine 23 . However, we did not detect CD73 expression in Tr1 cells (Fig. 1c) . In agreement with these findings, we detected CD39 but saw no CD73 enzymatic activity in Tr1 cells (Fig. 1d,e) . We also detected CD39 expression in human CD4 + T cells activated in the presence of IL-27 (ref. 24) (Supplementary Fig. 1d) .
To study the regulation of CD39 expression in Tr1 cells, we analyzed the Entpd1 promoter and identified three AHR-responsive elements (XRE1, XRE2 and XRE3) and a STAT3-responsive element (SRE) (Fig. 1f) . AHR binding to XRE-1 and XRE-2 and STAT3 binding to the SRE in the Entpd1 promoter was detected by chromatin immunoprecipitation (ChIP) assays in T cells activated under Tr1-polarizing conditions (Fig. 1g) . Moreover, AHR and constitutively activated STAT3 (STAT3c) transactivated the Entpd1 promoter in reporter assays (Fig. 1h) . Furthermore, using T cells harboring a hypomorphic Ahr allele (Ahr mut ) 25 or deficient in STAT3 (Stat3 −/− ) 26 , we found that CD39 is expressed in Tr1 cells in an AHR-and STAT3-dependent manner (Fig. 1i,j) .
We also found that STAT3 and AHR are recruited to the Ahr promoter in T cells activated under Tr1-polarizing conditions ( Supplementary Fig. 1e-g ). Moreover, AHR and STAT3c transactivated the Ahr promoter in reporter assays, and the upregulation of Ahr expression induced by IL-27 was abrogated in Stat3 −/− T cells ( Supplementary Fig. 1h,i) . Taken together, these data show that IL-27 induces CD39 expression in Tr1 cells via AHR and STAT3 signaling, and they identify a positive-feedback loop by which AHR, in combination with STAT3, promotes Ahr expression.
CD39 contributes to the suppressive function of Tr1 cells CD39 contributes to the suppressive activity of Foxp3 + T reg cells through its participation in the synthesis of adenosine 21, 27 . We found that CD39 deficiency reduced the suppressive activity of Tr1 cells in vitro (Fig. 2a) . To study the relevance of these findings for Tr1 cells in vivo, we transferred wild-type (WT) or CD39-deficient IL-10:GFP + Tr1 cells into C57BL/6 mice 10 d after the induction of experimental autoimmune encephalomyelitis (EAE) by immunization with myelin oligodendrocyte glycoprotein (MOG) ; Tr1 cells did not express Foxp3 (Supplementary Fig. 1j ). WT, but not CD39-deficient Tr1 cells, reduced the EAE clinical score and the interferon (IFN)-γ and IL-17 CD4 + T cell recall response to MOG (Fig. 2b,c) .
CD73 is required for the suppressive activity of Foxp3 + T reg cells 27 . Because we did not detect CD73 expression in Tr1 cells, we studied whether CD73 in responder T cells and antigen-presenting cells was needed for Tr1 cell-mediated suppression. We found that CD73 deficiency in responder T cells or DCs reduced the suppressive activity of Tr1 cells (Fig. 2d,e) .
To study the role of CD73 in responder T cells for their regulation by Tr1 cells in vivo, we used a transfer EAE model 28 . Briefly, WT or CD73-deficient (Nt5e −/− ) mice were immunized with MOG , and 7 d later CD4 + T cells were isolated and transferred into Rag1 −/− mice, which were then immunized with MOG to induce EAE. Ten days after EAE induction, WT or CD39-deficient Tr1 cells were transferred into the Rag1 −/− recipients and disease development was monitored (Fig. 2f) . WT Tr1 cells ameliorated EAE in mice reconstituted with WT T cells, but this amelioration was reduced in mice reconstituted with CD73-deficient T cells (Fig. 2g,h ). These data suggest that adenosine produced by CD39 in Tr1 cells in cooperation with CD73 expressed by responder T cells and antigen-presenting cells contributes to the suppressive activity of Tr1 cells.
We confirmed our findings on the role of CD39 on Tr1 suppressive activity using a T cell transfer colitis model. Briefly, we co-transferred CD90.1 + CD4 + CD25 -CD45RB hi effector T cells together with WT or CD39-deficient CD90.2 + GFP:IL-10 + Tr1 cells into Rag1 −/− recipients and monitored colitis development 29 . We found that CD39-deficient Tr1 cells failed to suppress the development of colitis (Fig. 2i,j) . CD39 deficiency resulted in lower numbers of total and IL-10:GFP + -transferred CD90.2 + CD4 + T cells in the lamina propria compared to WT cells, but it did not lead to their expression of IL-17 or Foxp3 (Fig. 2j and data not shown) . Collectively, these data show that CD39 is needed for Tr1 cell stability and immunoregulatory activity. Naive  T  H 0  Tr1  T  H 1  T  H 2  T  H 17  iT   regs   0   5   10   15   20 (Fig. 3a,b and Supplementary Fig. 2a ). In line with these in vitro findings, the differentiation of Tr1 cells was suppressed in Rag1 −/− mice reconstituted with CD39-deficient T cells and treated with CD3-specific antibodies as described 20, 31 (Fig. 3c) . Hence, CD39 promotes Tr1 cell differentiation.
T cell activation increases eATP levels as a result of the controlled release of cellular ATP 10 , and eATP interacts with purinergic receptors to regulate T cell function in an autocrine and paracrine manner 10 . CD39 catalyzes the degradation of eATP 22 . In support of a role for CD39 in limiting eATP levels during Tr1 cell differentiation, we detected higher amounts of eATP in culture supernatants from CD39-deficient T cells compared to WT cells (Fig. 3d) . On the basis of this finding, we analyzed the effects of eATP on Tr1 cell differentiation. eATP suppressed Tr1 cell differentiation in a dose-dependent manner (Fig. 3e) independently of cell death (Supplementary Fig. 2b) . The suppressive effects of eATP were increased in CD39-deficient T cells, suggesting that CD39 limits the inhibitory effects of eATP on Tr1 cell differentiation (Fig. 3e) . eATP and CD39 blockade also inhibited IL-10 expression in human T cells activated in the presence of IL-27 (ref. 24) (Supplementary Fig. 2c,d ).
P2X7 and other purinergic receptors mediate the effects of eATP [32] [33] [34] [35] . The inhibitory effects of eATP on Tr1 cell differentiation were abrogated in P2X7R-deficient, but not in P2Y2-deficient T cells or in cells treated with the P2X4R-specific inhibitor 5-BDBD ( Fig. 3f and data npg not shown). Indeed, the P2X7R-selective inhibitor A438079 rescued the differentiation of CD39-deficient Tr1 cells to levels comparable to those observed in WT T cells (Fig. 3g) . Taken together, these data demonstrate that P2X7R signaling triggered by eATP inhibits Tr1 cell differentiation in CD39-deficient T cells.
HIF1-a antagonizes AHR during Tr1 cell differentiation
We then investigated the mechanism by which eATP interferes with Tr1 cell differentiation. P2X7R activation by eATP regulates the expression of HIF1-α responsive genes in tumor cells 36, 37 . As HIF1-α regulates T cell differentiation 6-8 , we analyzed the effect of eATP on HIF1-α expression in Tr1 cells. HIF1-α is expressed after 72 h of Tr1 cell differentiation (Fig. 4a) ; this expression was lower than that detected in T H 17 cells and comparable to that observed in Foxp3 + iT reg cells (Supplementary Fig. 3a) . However, supplementation with exogenous eATP in CD39-deficient cells increased HIF1-α protein expression (Fig. 4a,b) . HIF1-α and AHR form a complex with the AHR nuclear translocator (ARNT) to regulate the expression of target genes 11, 38 . AHR has an important role in Tr1 cell differentiation 11, 20 . Thus, we analyzed AHR, HIF1-α and ARNT expression after Tr1 cell differentiation in the presence of eATP. ARNT expression remained stable after eATP supplementation, but HIF1-α expression increased concomitantly with a reduction in AHR levels ( Fig. 4c and Supplementary Fig. 3b ). We then studied whether the increase in HIF1-α protein expression induced by eATP interfered with AHR/ARNT complex formation. ARNT/AHR complexes decreased in the presence of exogenously added eATP ( Fig. 4d and Supplementary Fig. 3c ). Conversely, eATP increased the interaction of ARNT with HIF1-α, decreasing the AHR/HIF1-α binding ratio to ARNT (Fig. 4d and Supplementary Fig. 3c ).
HIF1-α promotes Foxp3 ubiquitination and its degradation by the proteasome in T H 17 cells 6 . Thus, we studied whether HIF1-α induction by eATP resulted in AHR ubiquitination and degradation in Tr1 cells. eATP treatment increased AHR ubiquitination ( Fig. 4e  and Supplementary Fig. 3d ). Indeed, in co-transfection experiments, expression of a stabilized variant of HIF1-α decreased AHR protein expression compared to that observed with an empty vector ( Fig. 4f  and Supplementary Fig. 3e ). This decrease in AHR protein levels was inhibited by treatment with the proteasome inhibitor MG132 (Fig. 4f and Supplementary Fig. 3e ). Moreover, in agreement with a role for HIF1-α in the regulation of AHR protein levels in T cells, under Tr1-polarizing conditions HIF1-α expression peaked 24 h after activation and decreased afterwards, whereas AHR expression peaked at 72 h once HIF1-α protein expression was diminished (Fig. 4g) . AHR interacts with genomic XRE sites in Il10, Il21 and Entpd1 to control their expression in Tr1 cells 20 (Fig. 1) . AHR, for example, is recruited to the Il10 promoter in Tr1 cells, but not in pathogenic T H 17, cells which express AHR but not IL-10 (refs. 20,21 and Supplementary Fig. 3f ). In agreement with our findings on the effects of HIF1-α on AHR stability, eATP supplementation decreased the recruitment of AHR to the Il10, Il21 and Entpd1 promoters during Tr1 cell differentiation (Fig. 4h) . Moreover, the co-expression of a stabilized variant of HIF1-α suppressed the transactivation of the Il10, Il21 and Entpd1 promoters by AHR in reporter assays (Fig. 4i) .
Finally, to confirm that the effects of eATP on Tr1 cell differentiation were mediated by HIF1-α, we transduced Cre recombinase into Hif1a fl/fl CD4 + T cells 24 h after activation under Tr1-polarizing conditions in the presence of eATP. In agreement with our results on AHR destabilization by HIF1-α, Hif1a deletion resulted in increased Tr1 cell differentiation (Fig. 4j) . Moreover, Hif1a deletion abrogated the suppression of Tr1 cell differentiation by eATP (Fig. 4j) , demonstrating that HIF1-α mediates the inhibitory effects of eATP on Tr1 cell differentiation.
Hypoxia suppresses Tr1 cell differentiation
In normoxic conditions, prolyl hydroxylase domain (PHD) proteins (encoded by Egln1, Egln2 and Egln3) promote the degradation of HIF1-α, whereas the HIF1-α inhibitor (encoded by Hif1an) inhibits its transcriptional activity 38, 39 . However, under hypoxic conditions, these proteins are inactive, resulting in the stabilization of HIF1-α and the induction of HIF1-α dependent cellular responses 39 . Hypoxia modulates T cell differentiation in a HIF1-α-dependent manner 6, 7 . Thus, we studied the effects of hypoxia on AHR and Tr1 cell Fig. 3g-i) . The inhibition of Tr1-cell differentiation was associated with increased HIF1-α protein expression at later time points and a concomitant decrease in AHR protein expression and recruitment to target promoters in Tr1 cells, such as Il10 and Entpd1 ( Fig. 4g and Supplementary  Fig. 3j ). Hence, these results demonstrate that HIF1-α induced by eATP or hypoxia interferes with AHR-dependent signaling and limits Tr1 cell differentiation.
HIF1-a controls Tr1 cell early metabolic reprogramming HIF1-α affects T cell activation and polarization into specific lineages [6] [7] [8] 40 . To further study the role of HIF1-α in Tr1 cells, we transduced Cre recombinase into Hif1a fl/fl CD4 cells at different time points during Tr1 cell differentiation (Supplementary Fig. 4a ).
Cre recombinase transduction 24 h after T cell activation boosted
Tr1 cell differentiation compared to controls, but notably, transduction at earlier time points (6 or 12 h after culture initiation) reduced the differentiation of Tr1 cells (Fig. 5a) . Moreover, Tr1 cell differentiation was suppressed in CD4 + T cells from CD4 Cre Hif1a fl/fl mice (Fig. 5b) . HIF1-α and AHR also affected the differentiation of T H 17 and Foxp3 + iT reg cells (Supplementary Fig. 4b ). HIF1-α performs important functions in the regulation of cellular metabolism [1] [2] [3] . Thus, considering the metabolic functions of HIF1-α and its early upregulation in Tr1 cells, we postulated that HIF1-α has a dual role in Tr1 cells: at later time points HIF1-α destabilizes AHR, but at earlier time points HIF1-α might control Tr1 cells' metabolic reprogramming. However, the metabolism of Tr1 cells is largely unknown.
A metabolomics analysis of T cells activated under Tr1-polarizing conditions detected a metabolite profile associated with aerobic glycolysis, similar to that of T H 17 cells and different from the oxidative npg phosphorylation associated with Foxp3 + T reg cells ( Fig. 5c and Supplementary Fig. 4c) . In support of a role for glycolysis in Tr1 cell differentiation, we detected increased glucose uptake and lactate production in T cells activated in the presence of IL-27 ( Fig. 5d,e) . T cell activation under Tr1-polarizing conditions did not affect mitochondria-dependent fatty acid β-oxidation or pyruvate oxidation through the tricarboxylic acid cycle (data not shown). Analysis of 84 metabolism-related genes detected increased expression of genes linked to glycolysis under Tr1-polarizing conditions. These transcripts included enolase 1 (Eno1), lactate dehydrogenase (Ldha), hexokinase 2 (Hk2) and the glucose transporter Glut1 (encoded by Slc2a1) (Fig. 5f,g ), suggesting that aerobic glycolysis contributes to Tr1 cell differentiation in a similar manner to what has been described for T H 17 cells 40 . Indeed, inhibition of glycolysis with 2-deoxyglucose (2-DG) suppressed the differentiation of Tr1 and T H 17 cells, whereas it boosted Foxp3 + T reg cell differentiation ( Fig. 5h and Supplementary Fig. 4d) . Thus, aerobic glycolysis is required for Tr1 cell differentiation.
To investigate the role of HIF1-α on the early metabolic reprograming of Tr1 cells we measured Eno1, Ldha, Hk2 and Slc2a1 expression in WT and HIF1-α-deficient T cells (Hif1a fl/fl CD4 Cre ), 24 h after activation under Tr1-polarizing conditions. HIF1-α deficiency suppressed the upregulation of these transcripts, as well glucose uptake and lactate production (Fig. 5i,j) . Taken together, these data suggest that HIF1-α participates in the control of glycolysis during the early stages of Tr1 cell differentiation. npg increased AHR expression (Fig. 4g) . To study the regulation of HIF1-α and AHR expression in Tr1 cells, we constructed a mathematical model that considered the regulation of AHR stability by HIF1-α, the ability of AHR to induce Ahr expression, and HIF1-α degradation by PHD proteins 38, 39 . This model did not fit our experimental observations, because it predicted a continued increase of HIF1-α expression (Model 1, Fig. 6a and Supplementary Fig. 5a,b) . Thus, we hypothesized that AHR may limit HIF1-α expression, and we generated a revised model in which AHR promotes HIF1-α degradation by inducing the expression of PHD proteins. The predictions of this model were in agreement with our experimental data (Model 2, Fig. 6a, and Supplementary Fig. 5b ), thus suggesting that AHR limits HIF1-α in Tr1 cells.
In support of a role for AHR in limiting HIF1-α cellular levels, we detected increased HIF1-α expression in Ahr mut T cells compared to WT (Fig. 6b) . Indeed, we detected AHR binding to the Egln1, Egln2 and Egln3 promoters under Tr1-polarizing conditions, and the expression of these genes was decreased in Ahr mut T cells (Fig. 6c,d) . Egln1, Egln2 and Egln3 were expressed by Foxp3 + iT reg cells but not by T H 17 cells, concomitant with a lack of AHR recruitment to the promoter of these genes in T H 17 cells ( Supplementary  Fig. 5c,d ). These data are in agreement with the promoting and inhibitory roles, respectively, of HIF1-α in T H 17 cell and Foxp3 + iT reg cell differentiation 6, 40 , and they suggest that lineage-specific factors control promoter accessibility to AHR.
HIF1-α participates in the control of glycolysis during the early stages of Tr1 cell differentiation, but its decreased expression at later time points suggests that other factors participate in the control of Tr1 cell metabolism. The expression of c-Myc and estrogen-related receptor-α (ERR-α), which have been linked to the regulation of glycolysis in T cells 41, 42 , did not differ between Tr1-or T H 0-polarizing conditions (Supplementary Fig. 5e ). However, we identified AHR binding sites in the promoters of Eno1, Ldha, Hk2 and Slc2a1 (Fig. 6e) . HIF1-α was recruited to these promoters 24 h after the initiation of Tr1 cell cultures, but by 48 h of activation the recruitment of HIF1-α was decreased, concomitant with an increased recruitment of AHR (Fig. 6e) . Indeed, AHR transactivated the Eno1, Ldha, Hk2 and Slc2a1 promoters to similar levels to those induced by HIF1-α (Fig. 6f) . Moreover, Ahr mut T cells activated under Tr1-polarizing conditions for 48 h showed decreased expression of genes linked to glycolysis, decreased glucose uptake and lactate production compared to WT Tr1 cells (Fig. 6g-i) . We did not observe differences in glycolytic genes in Ahr mut T cells activated under Tr1-polarizing conditions for 24 h (Fig. 6g) . We also failed to detect an increase in the recruitment of c-Myc to Eno1 and Ldha in Tr1 cells (Supplementary Fig. 5f ). Collectively, these data show that AHR participates in the control of metabolism during the late stages of Tr1 cell differentiation.
DISCUSSION
Metabolic reprogramming associated with T cell activation matches the bioenergetic needs of the immune system during the immune response. In addition, immunometabolites participate in immunoregulatory feedback loops. We found that through their effects on HIF1-α, eATP and hypoxia inhibit Tr1 cell differentiation. Both increased eATP and hypoxia characterize sites of inflammation 10, 22, 43 . Thus, our data identify a potential mechanism through which metabolites in the microenvironment of inflamed tissue modulate the immune response. This mechanism might be co-opted by other immune cells. Indeed, the production of IL-10 by both IL-27-induced Tr1 cells and T H 1 cells has been linked to the transcription factor c-Maf 18, 20, 44 , and CD39 also contributes to the control of inflammation by Foxp3 + T reg cells and dendritic cells 27, 34 . Thus, the cross-talk between HIF1-α and AHR provides a pathway for modulating the immune response in response to immunological, metabolic and environmental signals.
The metabolism of effector CD4 + and CD8 + T cells displays a strong bias toward glycolysis, while Foxp3 + T reg cells rely on oxidative phosphorylation to match their bioenergetic needs 7, 9, 40 . Our data demonstrate that regulatory Tr1 cells are supported by glycolytic metabolism. These metabolic similarities between effector and regulatory Tr1 cells are likely to reflect common metabolic needs associated with proliferative T cells 45 and the participation of STAT3-dependent transcriptional programs in the differentiation of Tr1 and T H 17 cells 15, 16, 46, 47 . Conversely, the different metabolic programs associated with Tr1 cells and Foxp3 + T reg cells might reflect the functional compartmentalization of these immunoregulatory cell populations in vivo. Moreover, these findings suggest therapeutic interventions to preferentially promote the differentiation of Tr1 or Foxp3 + T reg cells.
METHODS
Methods and any associated references are available in the online version of the paper. 
